Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR
- PMID: 32535397
- PMCID: PMC7278635
- DOI: 10.1016/j.jcv.2020.104499
Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR
Abstract
Background: The novel respiratory virus SARS-CoV-2, responsible for over 380,000 COVID-19 related deaths, has caused significant strain on healthcare infrastructure and clinical laboratories globally. The pandemic's initial challenges include broad diagnostic testing, consistent reagent supply lines, and access to laboratory instruments and equipment. In early 2020, primer/probe sets distributed by the CDC utilized the same fluorophore for molecular detection - requiring multiple assays to be run in parallel - consuming valuable and limited resources.
Methods: Nasopharyngeal swabs submitted to UW Virology for SARS-CoV-2 clinical testing were extracted, amplified by our laboratory developed test (LDT) - a CDC-based quantitative reverse transcriptase PCR reaction - and analyzed for agreement between the multiplexed assay. Laboratory- confirmed respiratory infection samples were included to evaluate assay cross-reaction specificity.
Results: Triplexing correctly identified SARS-CoV-2 in 98.4% of confirmed positive or inconclusive patient samples by single-plex LDT (n = 183/186). All 170 SARS-CoV-2 negative samples tested by single-plex LDT were negative by triplexing. Other laboratory-confirmed respiratory infections did not amplify for SARS-CoV-2 in the triplex reaction.
Conclusions: Multiplexing two virus-specific gene targets and an extraction control was found to be comparable to running parallel assays independently, while significantly improving assay throughput.
Keywords: COVID-19; LDT; Multiplex; RT-PCR; SARS-CoV-2; Triplex.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest.
Similar articles
-
Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance.J Clin Virol. 2020 Aug;129:104474. doi: 10.1016/j.jcv.2020.104474. Epub 2020 May 28. J Clin Virol. 2020. PMID: 32504946 Free PMC article.
-
Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline.J Clin Virol. 2020 Oct;131:104581. doi: 10.1016/j.jcv.2020.104581. Epub 2020 Aug 21. J Clin Virol. 2020. PMID: 32889496 Free PMC article.
-
Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories.J Clin Microbiol. 2020 Jul 23;58(8):e00821-20. doi: 10.1128/JCM.00821-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32350048 Free PMC article.
-
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
-
Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA.J Clin Microbiol. 2020 Jul 23;58(8):e00796-20. doi: 10.1128/JCM.00796-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32381642 Free PMC article. Review.
Cited by
-
The estimation of diagnostic accuracy of tests for COVID-19: A scoping review.J Infect. 2020 Nov;81(5):681-697. doi: 10.1016/j.jinf.2020.08.043. Epub 2020 Aug 31. J Infect. 2020. PMID: 32882315 Free PMC article.
-
Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assay.Sci Rep. 2021 Oct 14;11(1):20494. doi: 10.1038/s41598-021-99661-7. Sci Rep. 2021. PMID: 34650153 Free PMC article.
-
Coronavirus Disease 2019 (COVID-19) Diagnostic Tools: A Focus on Detection Technologies and Limitations.Curr Issues Mol Biol. 2021 Jul 20;43(2):728-748. doi: 10.3390/cimb43020053. Curr Issues Mol Biol. 2021. PMID: 34287238 Free PMC article. Review.
-
Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.J Med Virol. 2021 Oct;93(10):5931-5941. doi: 10.1002/jmv.27155. Epub 2021 Jul 3. J Med Virol. 2021. PMID: 34170525 Free PMC article.
-
Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach.Int J Biol Macromol. 2021 Oct 31;189:802-818. doi: 10.1016/j.ijbiomac.2021.08.095. Epub 2021 Aug 18. Int J Biol Macromol. 2021. PMID: 34418419 Free PMC article. Review.
References
-
- Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
-
- Wighton K., van Elsland S.L. Imperial News; Imperial College London: 2020. Coronavirus Fatality Rate Estimated by Imperial Scientists.https://www.imperial.ac.uk/news/195217/coronavirus-fatality-rate-estimat... Imperial News.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous